|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Securities available-for-sale | ||||||||||||||||
| Federal Home Loan Bank stock | ||||||||||||||||
| Other investments | ||||||||||||||||
| Mortgage loans held for sale, at fair value | ||||||||||||||||
| Loans: | ||||||||||||||||
| Originated | ||||||||||||||||
| Acquired | ||||||||||||||||
| Total loans | ||||||||||||||||
| Less: Allowance for loan losses | ||||||||||||||||
| Net loans | ||||||||||||||||
| Premises and equipment, net | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Mortgage servicing rights, net | ||||||||||||||||
| Core deposit intangibles, net | ||||||||||||||||
| Other real estate owned | ||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||
| Income tax benefit | ||||||||||||||||
| Other assets | ||||||||||||||||
| Interest receivable and other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Deposits: | ||||||||||||||||
| Noninterest-bearing demand deposits | ||||||||||||||||
| Interest-bearing demand deposits | ||||||||||||||||
| Money market and savings deposits | ||||||||||||||||
| Time deposits | ||||||||||||||||
| Total deposits | ||||||||||||||||
| Borrowings | ||||||||||||||||
| Subordinated notes | ||||||||||||||||
| Other liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Shareholders' equity | ||||||||||||||||
| Preferred stock, no par value per share; authorized—50,000 shares; issued and outstanding—10,000 shares, with a liquidation preference of $2,500 per share, at December 31, 2021 and 2020 | ||||||||||||||||
| Common stock, no par value per share; authorized—20,000,000 shares; issued and outstanding—7,733,726 shares at December 31, 2021 and 7,633,780 shares at December 31, 2020 | ||||||||||||||||
| Retained earnings | ||||||||||||||||
| Accumulated other comprehensive income, net of tax | ||||||||||||||||
| Total shareholders' equity | ||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||
Loading...
